Global Information
회사소개 | 문의 | 비교리스트

세계의 원료의약품(API) 시장 : 합성 유형별, 제조업체 유형별, 유형별, 애플리케이션별, 지역별 시장 규모 조사와 예측(2021-2027년)

Global Active Pharmaceutical Ingredients Market Size study, by Type of Synthesis, by Type of Manufacturer, by Type, by Application, and Regional Forecasts 2021-2027

리서치사 Bizwit Research & Consulting LLP
발행일 2021년 05월 상품코드 1007786
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,950 ₩ 7,031,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 8,878,000 Printable PDF (Enterprise License)


세계의 원료의약품(API) 시장 : 합성 유형별, 제조업체 유형별, 유형별, 애플리케이션별, 지역별 시장 규모 조사와 예측(2021-2027년) Global Active Pharmaceutical Ingredients Market Size study, by Type of Synthesis, by Type of Manufacturer, by Type, by Application, and Regional Forecasts 2021-2027
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 원료의약품(API) 시장 규모는 2020년에 약 1,848억 달러를 기록했으며, 2021-2027년의 예측 기간 중 6.90%를 넘는 건전한 성장률로 성장할 것으로 예상되고 있습니다.

원료의약품(API)은 의약품의 제조에 사용되는 물질 또는 물질의 혼합물이며, 의약품의 제조에 사용되면 의약품 유효 성분이 됩니다. API는 질환의 분석, 치료, 완화, 진단 또는 예방에서 약리학적 활성 또는 기타 직접적인 효과를 제공하는 것을 목적으로 하고 있습니다.

API는 제약 업계의 구성요소입니다. COVID-19 팬데믹 후 업계의 지수함수적 성장에 의해 API의 수요가 증가했습니다. 팬데믹의 록다운 중 의약품 공급망이 대폭 혼란해지며, 전 세계에서 API가 부족했습니다. 인도 및 기타 아시아 국가를 포함한 다양한 정부는 현재 중국에 대한 의존을 줄이기 위해 국내에서 API의 성장을 가속시키려고 하고 있습니다. 이 노력은 또한 원료의약품 시장의 성장을 촉진하고 있습니다.

2020년, 인도 정부는 API의 국내 제조를 촉진하기 위한 Production Linked Incentive(PLI) 스킴을 발표했습니다. 이 스킴에서는 53개의 API를 6년간 커버하는 식별된 41개 적격 제품의 적격 제조업체에게 금전적 장려책이 제공됩니다. 정부에 의한 다른 스킴에서는 3개의 벌크 드러그 파크에 공통 인프라 시설을 건설하기 위한 자금 원조를 제공하기 위해 3,000 루피가 할당되어 있습니다.

세계의 원료의약품(API) 시장을 조사했으며, 시장의 개요, 시장 성장요인 및 저해요인 분석, 시장 기회, 합성 유형·제조업체 유형·유형·애플리케이션·지역별 시장 규모의 추이와 예측, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 시장의 정의와 범위

제3장 시장 역학

  • 시장의 영향 분석(2019-2027년)

제4장 업계 분석

  • Porter의 산업 분석
  • PEST 분석
  • 투자 채택 모델
  • 애널리스트의 추천 사항과 결론

제5장 합성 유형별

  • 시장 스냅숏
  • 퍼포먼스 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년(10억 달러 단위)
  • 하위 부문 분석
    • 바이오테크놀러지 API
    • 모노클로널 항체
    • 재조합 단백질
    • 백신
    • 합성 API

제6장 제조업체 유형별

  • 시장 스냅숏
  • 퍼포먼스 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년(10억 달러 단위)
  • 하위 부문 분석
    • 캡티브 API
    • 머천트 API

제7장 유형별

  • 시장 스냅숏
  • 퍼포먼스 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년(10억 달러 단위)
  • 하위 부문 분석
    • 제네릭 API
    • 혁신적 API

제8장 애플리케이션별

  • 시장 스냅숏
  • 퍼포먼스 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년(10억 달러 단위)
  • 하위 부문 분석
    • 심혈관질환
    • 종양학
    • 중추신경계와 신경학
    • 정형외과
    • 내분비학
    • 호흡기학
    • 소화기병학
    • 신장학
    • 안과
    • 기타

제9장 지역별

  • 지역 시장 스냅숏
  • 북미
    • 미국
    • 캐나다
  • 유럽 스냅숏
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 아시아태평양 스냅숏
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카 스냅숏
    • 브라질
    • 멕시코
  • 기타 지역

제10장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • AbbVie, Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Cipla, Inc.
    • Merck & Co., Inc.
    • Albemarle Corporation
    • Aurobindo Pharma
    • Viatris Inc.(Mylan N.V.)
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.

제11장 조사 프로세스

KSA 21.06.25

LIST OF TABLES

  • TABLE 1. Global Active Pharmaceutical Ingredients Market, report scope
  • TABLE 2. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Type of Synthesis 2018-2027 (USD Billion)
  • TABLE 4. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Type of Manufacturer 2018-2027 (USD Billion)
  • TABLE 5. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Type 2018-2027 (USD Billion)
  • TABLE 6. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Application 2018-2027 (USD Billion)
  • TABLE 7. Global Active Pharmaceutical Ingredients Market estimates & forecasts by 2018-2027 (USD Billion)
  • TABLE 8. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. U.S. Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. U.S. Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 20. U.S. Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 21. Canada Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. Canada Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. Canada Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. UK Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 25. UK Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. UK Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. Germany Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 28. Germany Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. Germany Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. RoE Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 31. RoE Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. RoE Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. China Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 34. China Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. China Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. India Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 37. India Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. India Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Japan Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 40. Japan Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Japan Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. RoAPAC Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 43. RoAPAC Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. RoAPAC Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. Brazil Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 46. Brazil Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. Brazil Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. Mexico Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 49. Mexico Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. Mexico Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. RoLA Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 52. RoLA Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. RoLA Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Row Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 55. Row Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Row Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 57. List of secondary sources, used in the study of global Active Pharmaceutical Ingredients Market
  • TABLE 58. List of primary sources, used in the study of global Active Pharmaceutical Ingredients Market
  • TABLE 59. Years considered for the study
  • TABLE 60. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Active Pharmaceutical Ingredients Market, research methodology
  • FIG 2. Global Active Pharmaceutical Ingredients Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Active Pharmaceutical Ingredients Market, key trends 2020
  • FIG 5. Global Active Pharmaceutical Ingredients Market, growth prospects 2021-2027
  • FIG 6. Global Active Pharmaceutical Ingredients Market, porters 5 force model
  • FIG 7. Global Active Pharmaceutical Ingredients Market, pest analysis
  • FIG 8. Global Active Pharmaceutical Ingredients Market, value chain analysis
  • FIG 9. Global Active Pharmaceutical Ingredients Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Active Pharmaceutical Ingredients Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Active Pharmaceutical Ingredients Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Active Pharmaceutical Ingredients Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Active Pharmaceutical Ingredients Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Active Pharmaceutical Ingredients Market, regional snapshot 2018 & 2027
  • FIG 15. North America Active Pharmaceutical Ingredients Market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Active Pharmaceutical Ingredients Market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Active Pharmaceutical Ingredients Market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Active Pharmaceutical Ingredients Market 2018 & 2027 (USD Billion)
  • FIG 19. Global Active Pharmaceutical Ingredients Market, company market share analysis (2020)

Global Active Pharmaceutical Ingredients Market is valued approximately USD 184.8 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.90% over the forecast period 2021-2027. Active pharmaceutical ingredient is a substance or mixture of substances used in the manufacturing of a medicinal drug and becomes an active ingredient of the drug product, when used in the production of a drug. APIs are intended to furnish pharmacological activity or any other direct effect in the analysis, treatment, mitigation, diagnosis or prevention of a disease. The APIs are the building blocks of pharmaceutical industry. The exponential growth of the industry after the COVID-19 pandemic has increased the demand of APIs. Pharmaceutical supply chain was heavily disrupted during lockdowns in pandemic which resulted in shortage of APIs worldwide. The various governments, including Indian and other Asian countries, are now trying to ramp up the growth of APIs domestically to reduce the dependency on China. These efforts are also driving the growth of active pharmaceutical ingredients market. In 2020, Government of India announced Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of APIS, in which financial incentive will be given to eligible manufacturers of identified 41 eligible products which covers 53 APIs for 6 years. Another scheme from government allots INR 3000 Crores for providing financial assistance for construction of Common Infrastructure Facilities in 3 Bulk Drug Parks.

The high cost of setting up API production units and stringent safety regulations and governmental norms may act as a restraint for its growth. However, increasing chronic diseases due to lifestyle changes such as cardiovascular, respiratory and others act as an opportunity for growth of Active Pharmaceutical Ingredients Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Active Pharmaceutical Ingredients Market. Due to the presence of leading pharmaceutical formulation manufacturers as well as rise of lifestyle diseases, North America is a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing pharmaceuticals industries in emerging economies of China and India. Government backed schemes and policies will also boost growth of API market in this region.

Major market player included in this report are:

AbbVie, Inc.

Boehringer Ingelheim International GmbH

Bristol-Myers Squibb Company

Cipla, Inc.

Merck & Co., Inc.

Albemarle Corporation

Aurobindo Pharma

Viatris Inc. (Mylan N.V.)

Teva Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Synthesis:

Biotech API

Monoclonal Antibodies

Recombinant Proteins

Vaccines

Synthetic API

By Type of Manufacturer:

Captive API

Merchant API

By Type:

Generic APIS

Innovative APIs

By Application:

Cardiovascular Diseases

Oncology

CNS and Neurology

Orthopedics

Endocrinology

Pulmonology

Gastroenterology

Nephrology

Ophthalmology

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Active Pharmaceutical Ingredients Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2019-2027 (USD Billion)
    • 1.2.2. Active Pharmaceutical Ingredients Market, by Type of Manufacturer, 2019-2027 (USD Billion)
    • 1.2.3. Active Pharmaceutical Ingredients Market, by Type, 2019-2027 (USD Billion)
    • 1.2.4. Active Pharmaceutical Ingredients Market, by Application, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Active Pharmaceutical Ingredients Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Active Pharmaceutical Ingredients Market Dynamics

  • 3.1. Active Pharmaceutical Ingredients Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Exponential growth of pharmaceutical industry
      • 3.1.1.2. Governmental proposed policies and schemes
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of production of APIs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in lifestyle diseases such as diabetes and cardiovascular

Chapter 4. Global Active Pharmaceutical Ingredients Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Active Pharmaceutical Ingredients Market, by Type of Synthesis

  • 5.1. Market Snapshot
  • 5.2. Global Active Pharmaceutical Ingredients Market by Type of Synthesis, Performance - Potential Analysis
  • 5.3. Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Type of Synthesis 2018-2027 (USD Billion)
  • 5.4. Active Pharmaceutical Ingredients Market, Sub Segment Analysis
    • 5.4.1. Biotech API
    • 5.4.2. Monoclonal Antibodies
    • 5.4.3. Recombinant Proteins
    • 5.4.4. Vaccines
    • 5.4.5. Synthetic API

Chapter 6. Global Active Pharmaceutical Ingredients Market, by Type of Manufacturer

  • 6.1. Market Snapshot
  • 6.2. Global Active Pharmaceutical Ingredients Market by Type of Manufacturer, Performance - Potential Analysis
  • 6.3. Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Type of Manufacturer 2018-2027 (USD Billion)
  • 6.4. Active Pharmaceutical Ingredients Market, Sub Segment Analysis
    • 6.4.1. Captive API
    • 6.4.2. Merchant API

Chapter 7. Global Active Pharmaceutical Ingredients Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Active Pharmaceutical Ingredients Market by Type, Performance - Potential Analysis
  • 7.3. Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
  • 7.4. Active Pharmaceutical Ingredients Market, Sub Segment Analysis
    • 7.4.1. Generic APIS
    • 7.4.2. Innovative APIs

Chapter 8. Global Active Pharmaceutical Ingredients Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Active Pharmaceutical Ingredients Market by Application, Performance - Potential Analysis
  • 8.3. Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
  • 8.4. Active Pharmaceutical Ingredients Market, Sub Segment Analysis
    • 8.4.1. Cardiovascular Diseases
    • 8.4.2. Oncology
    • 8.4.3. CNS and Neurology
    • 8.4.4. Orthopedics
    • 8.4.5. Endocrinology
    • 8.4.6. Pulmonology
    • 8.4.7. Gastroenterology
    • 8.4.8. Nephrology
    • 8.4.9. Ophthalmology
    • 8.4.10. Others

Chapter 9. Global Active Pharmaceutical Ingredients Market, Regional Analysis

  • 9.1. Active Pharmaceutical Ingredients Market, Regional Market Snapshot
  • 9.2. North America Active Pharmaceutical Ingredients Market
    • 9.2.1. U.S. Active Pharmaceutical Ingredients Market
      • 9.2.1.1. Type of Synthesis breakdown estimates & forecasts, 2018-2027
      • 9.2.1.2. Type of Manufacturer breakdown estimates & forecasts, 2018-2027
      • 9.2.1.3. Type breakdown estimates & forecasts, 2018-2027
      • 9.2.1.4. Application breakdown estimates & forecasts, 2018-2027
    • 9.2.2. Canada Active Pharmaceutical Ingredients Market
  • 9.3. Europe Active Pharmaceutical Ingredients Market Snapshot
    • 9.3.1. U.K. Active Pharmaceutical Ingredients Market
    • 9.3.2. Germany Active Pharmaceutical Ingredients Market
    • 9.3.3. France Active Pharmaceutical Ingredients Market
    • 9.3.4. Spain Active Pharmaceutical Ingredients Market
    • 9.3.5. Italy Active Pharmaceutical Ingredients Market
    • 9.3.6. Rest of Europe Active Pharmaceutical Ingredients Market
  • 9.4. Asia-Pacific Active Pharmaceutical Ingredients Market Snapshot
    • 9.4.1. China Active Pharmaceutical Ingredients Market
    • 9.4.2. India Active Pharmaceutical Ingredients Market
    • 9.4.3. Japan Active Pharmaceutical Ingredients Market
    • 9.4.4. Australia Active Pharmaceutical Ingredients Market
    • 9.4.5. South Korea Active Pharmaceutical Ingredients Market
    • 9.4.6. Rest of Asia Pacific Active Pharmaceutical Ingredients Market
  • 9.5. Latin America Active Pharmaceutical Ingredients Market Snapshot
    • 9.5.1. Brazil Active Pharmaceutical Ingredients Market
    • 9.5.2. Mexico Active Pharmaceutical Ingredients Market
  • 9.6. Rest of The World Active Pharmaceutical Ingredients Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. AbbVie, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Boehringer Ingelheim International GmbH
    • 10.2.3. Bristol-Myers Squibb Company
    • 10.2.4. Cipla, Inc.
    • 10.2.5. Merck & Co., Inc.
    • 10.2.6. Albemarle Corporation
    • 10.2.7. Aurobindo Pharma
    • 10.2.8. Viatris Inc. (Mylan N.V.)
    • 10.2.9. Teva Pharmaceutical Industries Ltd.
    • 10.2.10. Sun Pharmaceutical Industries Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
Back to Top
전화 문의
F A Q